Related Articles
Additional effect of anthracycline in preoperative chemotherapy with a sequential anthracycline‑containing regimen preceded by pertuzumab, trastuzumab and docetaxel combination therapy
Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2‑positive breast cancer in Japan
Long‑responders to anti‑HER2 therapies: A case report and review of the literature
Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer
Safety and efficacy of pyrotinib for HER‑2‑positive breast cancer in the neoadjuvant setting: A systematic review and meta‑analysis